Expanding Access to Care Through Telemedical Support for Vital Sign Monitoring in High-risk Patients With Cancer
- Disease/Condition
- Hypertension
- Drug/Device/Intervention
- Cellular enabled blood pressure cuff
- Study type
- Interventional
- Intervention type
- device
- Primary sponsor
- West Michigan Cancer Center
- Location
- Kalamazoo, United States of America
- Phase
- N/A
- Start date
- Mar 11, 2024
- End date
- Sep 01, 2025
- Enrollment
- 72 participants
To determine whether remote blood pressure monitoring improves adherence to recommendations for daily systolic and diastolic blood pressure monitoring compared to usual care
A randomized trial of remote blood pressure monitoring, compared to usual care, in patients
 receiving bevacizumab to determine whether remote blood pressure monitoring improves the
 collection of blood pressure data, identification and management of clinically significant
 hypertension, and patient satisfaction.
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT06364748
- Type
- Device Trial
Access comprehensive clinical trial information for NCT06364748 through Pure Global AI's free database. This phase not specified trial is sponsored by West Michigan Cancer Center and is currently Recruiting. The study focuses on Hypertension. Target enrollment is 72 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.